Exebacase: A Novel Approach to the Treatment of Staphylococcal Infections Matthew W. McCarthy Review Article Open access 17 February 2022 Pages: 113 - 117
Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease Liangying GanPanpan XieLi Zuo Original Research Article Open access 05 April 2022 Pages: 119 - 129
First-in-Human Phase I Study of the Novel Injectable Calcimimetic Agent Upacicalcet in Healthy Adult Japanese Participants Fumihiko KoiwaRie YazawaTadao Akizawa Original Research Article Open access 25 March 2022 Pages: 131 - 140
A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects Ashit TrivediOmar MatherEdward Lee Original Research Article Open access 13 March 2022 Pages: 141 - 146
Evaluation of the Pharmacokinetics and Safety of AMG 986 Tablet and Capsule Formulations in Healthy Adult Subjects: A Phase I, Open-Label, Randomized Study Ashit TrivediY.-H. KiangEdward Lee Original Research Article Open access 12 April 2022 Pages: 147 - 154
Hydroxychloroquine Blood Concentrations Can Be Clinically Relevant Also After Drug Discontinuation Simona De GregoriFrancesco FalaschiAntonio Di Sabatino Original Research Article Open access 13 May 2022 Pages: 155 - 163
Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9 Theodore J. KottomKyle SchaefbauerAndrew H. Limper Original Research Article Open access 29 April 2022 Pages: 165 - 173
Evaluation of the Effect of Food on the Pharmacokinetics of SHR6390, An Oral CDK4/6 Inhibitor, in Healthy Volunteers Yan-ping LiuMing-hui HuYu Cao Original Research Article Open access 30 May 2022 Pages: 175 - 182
